Gw Pharmaceuticals Quote - GWP | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
UK
LSE
GW Pharm. (GWP) Share Price

GW Pharm. (GWP)

735.00

0.00

(0.00%)

Closed 03 December 3:30AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

735.00

Bid

0.00

Offer

0.00

Volume

0.00

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

735.00

Open

-

Last Trade

Last Trade Time

Average Volume (3m)

-

Financial Volume

-

VWAP

-

GW Pharmaceuticals Annual Loss Widens As It Focuses On Epidiolex

News) - GW Pharmaceuticals PLC Monday said it was focused on the approval of its flagship drug Epidiolex in childhood- ...

GW Announces New Epidiolex® (CBD) Positive Phase 3 Data in Dravet Syndrome and Lennox-Gastaut Syndrome

- Posters Presented at American Epilepsy Society Annual Meeting -- New data includes key secondary efficacy endpoints - LONDON, Dec. 05, 2016 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc...

AIM Cancellation - GW Pharmaceuticals Plc

AIM 05 December 2016 NOTICE 05/12/2016 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM GW PHARMACEUTICALS PLC At the request of the company trading on AIM for the under-mentioned...

GW Pharmaceuticals PLC American Society of Epilepsy Annual Meeting

GW Pharmaceuticals PLC 01 December 2016 GW Pharmaceuticals plc Announces Epidiolex(R) (cannabidiol) Data Presentations and Educational Programs at the American Society of Epilepsy Annual Meeting...

GW Pharmaceuticals plc Announces Epidiolex® (cannabidiol) Data Presentations and Educational Programs at the American Societ...

- Presentations include clinical results from Phase 3 programs in Lennox-Gastaut Syndrome and Dravet Syndrome, as well as additional independent reports from Epidiolex Expanded Access...

GW Pharmaceuticals PLC Notice of Q4 and year-end results

GW Pharmaceuticals PLC 30 November 2016 GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016 London, UK, 30 Nov 2016: GW Pharmaceuticals plc...

GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016

LONDON, Nov. 30, 2016 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and...

GW Pharmaceuticals PLC Holding(s) in Company

GW Pharmaceuticals PLC 24 November 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 1. Identity of the issuer or GW Pharmaceuticals PLC the underlying issuer of existing shares to which...

GW Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference on 29 November

LONDON, Nov. 22, 2016 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ORCPOracle Power Plc	0.0555p (73.44%)	4.56B
SCESurface Transforms Plc	0.26p (40.54%)	83.35M
BLUBlue Star Capital Plc	0.0175p (40.00%)	122.99M
KBTK3 Business Technology Group Plc	87.50p (40.00%)	42.2k
PIPPipehawk Plc	1.85p (37.04%)	901.02k
GRLGoldstone Resources Limited	1.00p (-36.51%)	10.23M
ARBArgo Blockchain Plc	6.125p (-24.38%)	118.87M
BCEBeacon Energy Plc	0.00275p (-21.43%)	249.17M
SYMESupply@me Capital Plc	0.003p (-16.67%)	233.52M
BBBBigblu Broadband Plc	35.50p (-13.41%)	664.18k
ORCPOracle Power Plc	0.0555p (73.44%)	4.56B
NTVONativo Resources Plc	0.0025p (0.00%)	764.18M
PREMPremier African Minerals Limited	0.055p (0.92%)	601.66M
TRPTower Resources Plc	0.0295p (-4.84%)	470.43M
MSMNMosman Oil And Gas Limited	0.0415p (3.75%)	369.68M

3331

3331 5 minutes ago

BIEL #7 BREAKOUT BOARD #9 MOST READ LAST HOUR!

3331

3331 6 minutes ago

BIEL #7 BREAKOUT BOARD #9 MOST READ LAST HOUR!

toohot

toohot 6 minutes ago

BUY BUY BUY or BYE BYE BYE.
‘Nuff said!

BUY $BIEL$

getReady

getReady 7 minutes ago

There is always that thought. It's now been 12 days past due. The OTC Market typically updates around 1 am Eastern.

toohot

toohot 9 minutes ago

Agreed. Good post. Totally agree!

BUY $BIEL$

bigstocksnbonds

bigstocksnbonds 9 minutes ago

Great you got your fence approved and got started on it YAAY YOU!!

rogers711

rogers711 9 minutes ago

Ya I don't love the isopet venture... it hardly brings in any money... I honestly thought isopet was to prove efficacy to pave the path for human trials...

cableguy

cableguy 9 minutes ago

Then why would they wait? they have not been this long at filing before since inception of the shell, so why would a company file a NT10Q? what? companies that are just out to fleece the traders, could be possible, but why would have they paid they wouldn't have paid 50,000$ to raise the A/S to 5,00

harry crumb

harry crumb 10 minutes ago

A video! Lmao, who cares! Typical pennystock company here, releasing video's. Scam written all over it folks

TRAPPER JIM

TRAPPER JIM 10 minutes ago

You're welcome. Finally got the application approved for our fence. I broke ground on it tonight after work. I dug two fence post holes. Lol

G_rokk

G_rokk 11 minutes ago

Only information relevant to IDE and human trials in USA will move us up

FACT-MASTER

FACT-MASTER 11 minutes ago

Given the results thus far on the heme program, is FDA approval possible next week at /or after ASH?
I recall TSC100/101 had RMAT designation, mgmt. references a "registrational trial" for 2025, however is it not possible at times to receive FDA approval under RMAT designation, begin to admin

Golden Cross

Golden Cross 11 minutes ago

$ILLR New IR Video Covering New CEO Hire
https://www.youtube.com/watch?v=qekQ8El7_Ms

[yt]qekQ8El7_Ms[/yt]

3331

3331 12 minutes ago

BIEL #7 BREAKOUT BOARD #9 MOST READ LAST HOUR!

dinogreeves

dinogreeves 12 minutes ago

1000 more followers since yesterday on Stocktwits, 7000 more followers since 2 weeks ago. If this trend continues and we are sitting at 60,000 by year end possible, that is right around the range GM*E and AMC* started.

ysung

ysung 12 minutes ago

He is an idiot !!!

I would not even waste time talking to someone like Joe Biden

XRP ETF application filed by 4 USA CO's including Wisdom Tree

SEC lawsuit to be dropped
Stable coin to launch this week

This is payment based crypt

Konaploinks

Konaploinks 13 minutes ago

Tomorrow’s webinar should be very interesting to say the least. Forte Enterprise at our third data center in Switzerland is about to come online! $$$$ I think the road to profitability is about to be revealed. So much is going on with this corporation at once it’s mind boggling. I think Peter must h

Ecomike

Ecomike 14 minutes ago

Major IFUS news out today:

https://www.otcmarkets.com/otcapi/company/dns/news/document/78828/content

HyphenDubenator

HyphenDubenator 14 minutes ago

A few things about IQSTEL's Air Web (AW) AI Call Center Platform to consider...

AW is LLM Agonistic (will work with all popular Large Language Models )

Meta: LLAMA 2
ASW: Claude
MS: Co-Pilot
Google: Gemini
Open AI: ChatGPT 4,5
And

Gw Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions